Concepedia

Mark Talbot

MT

Statistics

Publications

9

Citations

215

H-Index

9

Active since

1989

Affiliations

Thrombosis Research Institute(Current)

Novartis (United Kingdom)

Royal Society for the Prevention of Cruelty to Animals

Mark Talbot is an author at Thrombosis Research Institute specializing in pharmacology, antithrombotic therapy, and medicine.

Publications per year

1989–2009

9

Publications

9

Recombinant Desulphatohirudin (CGP 39393) Anticoagulant and Antithrombotic Properties In Vivo

Mark Talbot, John Ambler, K. Butler et al. · Thrombosis and Haemostasis · 1989 · 52 citations

, , +16

The characterisation of thrombus development in an improved model of arterio-venous shunt thrombosis in the rat and the effects of recombinant desulphatohirudin (CGP 39393), heparin, and iloprost.

R F Peters, Christopher M. Lees, Kevin Mitchell et al. · PubMed · 1991 · 47 citations

, , +17

Design and Synthesis of Thrombin Inhibitors:  Analogues of MD-805 with Reduced Stereogenicity and Improved Potency

Derek E. Brundish, Alice Bull, Vera Donovan et al. · Journal of Medicinal Chemistry · 1999 · 30 citations · Full text

, , +14

Factor VIII and DDAVP reverse the effect of recombinant desulphatohirudin (CGP 39393) on bleeding in the rat

Kevin Butler, Sara L. Dolan, Mark Talbot et al. · Blood Coagulation & Fibrinolysis · 1993 · 27 citations

, , +15

The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position

Urs Baettig, Lyndon Brown, Derek E. Brundish et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 13 citations · Full text

, , +14

1–5 of 9